A randomized, crossover evaluation of me
โ
Mary B. Wilwerding; Charles L. Loprinzi; James A. Mailliard; Judith R. O'Fallon;
๐
Article
๐
1995
๐
Springer-Verlag
๐
English
โ 357 KB
Sedation may be a doselimiting side-effect of opioid therapy in some cancer patients. This study was designed to evaluate further the use of the psychostimulant, methylphenidate, an agent that has been reported to counteract opioid-induced sedation, in patients with cancer-related pain. Pa-tients re